Benzimidazoles
Abcam Albendazole, Microtubule depolymerizing agent, 10G
MW 265.33 Da, Purity >98%. Anthelmintic benzimidazole and microtubule depolymerizing agent. Able to inhibit brain microtubule polymerization in vitro and delays microtubule assembly in vivo. Anti-tumour activity seen in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical 4-desmethoxy Omeprazole 10mg
A potential impurity found in commercial omeprazole and esomeprazole magnesium preparations
Medchemexpress LLC Omeprazole (sodium) | 95510-70-6 | 99.1% | C17H18N3NaO3S | 1 ML
Omeprazole sodium is a proton pump inhibitor (PPI) used to treat acid-related gastrointestinal disorders. It competitively inhibits CYP2C19 activity and also inhibits the growth of Gram-positive and Gram-negative bacteria. It acts as a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor.
- Proton pump inhibitor
- Treats acid-related gastrointestinal disorders
- Inhibits CYP2C19 activity
- Inhibits growth of Gram-positive and Gram-negative bacteria
- Potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor
- Purity: 99.1%
- Chemical formula: C17H18N3NaO3S
- Molecular Weight: 367.40
- Appearance: Solid
- Melting/freezing point: >165°C
Medchemexpress LLC (R)-Omeprazole sodium | 161796-77-6 | 98.1% | 100 MG
(R)-Omeprazole sodium is a gastric acid resistant compound that inhibits gastric acid secretion. It is primarily metabolized by cytochrome P450 enzymes in vivo, and its interaction with mannitol may affect its bioavailability in formulations. This compound exhibits reversible direct and metabolism-dependent inhibition of CYP2C19. It is intended for research use only.
- Gastric acid resistant compound
- Inhibits gastric acid secretion
- Metabolism affected by cytochrome P450 enzymes
- May interact with mannitol affecting bioavailability
- Exhibits reversible direct and metabolism-dependent inhibition of CYP2C19
- For research use only
Medchemexpress LLC Omeprazole sulfide-d3 | 922730-98-1 | MFCD09841123 | 99.8% | C17H16D3N3O2S | 10MG
Omeprazole sulfide-d3 is the deuterium-labeled analogue of omeprazole sulfide, supplied as a stable isotope reference standard for analytical and metabolic studies. It is intended for use as an internal standard in quantitative mass spectrometry and pharmacokinetic investigations.
- Deuterium-labeled internal standard for LC-MS quantitation.
- High purity (99.8%).
- Suitable for metabolic and pharmacokinetic studies.
- Small package sizes convenient for analytical workflows.
- Stable as a powder at -20 °C for long-term storage; follow solvent storage recommendations.
- Handling notes: hygroscopic DMSO affects solubility; aliquot and avoid repeated freeze-thaw.
Apexbio Technology LLC OMEPRAZOLE-SULFONE-10MG
Omeprazole sulfone (CAS No 88546-55-8) is a key metabolite of omeprazole in the proton pump inhibitor category Originating from the necessity to understand omeprazole s pharmacokinetics it primarily targets the H /K ATPase enzyme system in gastric parietal cells inhibiting acid secretion Its mechanism involves the binding and alteration of specific pathways related to gastric acid production Omeprazole sulfone exhibits in vitro activity typically in the nanomolar to low micromolar range depending on experimental conditions It is commonly used in a variety of applications such as cell models animal studies and drug screening to explore gastric acid-related processes Experimental concentrations typically depend on the specific research design This compound is instrumental in evaluating the efficacy and safety of proton pump inhibitors and is pivotal in the research of gastro-related disorders and their treatment pathways
Apexbio Technology LLC OMEPRAZOLE-SULFONE-5MG
Omeprazole sulfone (CAS No 88546-55-8) is a key metabolite of omeprazole in the proton pump inhibitor category Originating from the necessity to understand omeprazole s pharmacokinetics it primarily targets the H /K ATPase enzyme system in gastric parietal cells inhibiting acid secretion Its mechanism involves the binding and alteration of specific pathways related to gastric acid production Omeprazole sulfone exhibits in vitro activity typically in the nanomolar to low micromolar range depending on experimental conditions It is commonly used in a variety of applications such as cell models animal studies and drug screening to explore gastric acid-related processes Experimental concentrations typically depend on the specific research design This compound is instrumental in evaluating the efficacy and safety of proton pump inhibitors and is pivotal in the research of gastro-related disorders and their treatment pathways
Medchemexpress LLC (R)-Omeprazole (sodium) | 161796-77-6 | 98.1% | 250 MG
(R)-Omeprazole sodium is a gastric acid resistant compound that inhibits gastric acid secretion. It is primarily metabolized in vivo by cytochrome P450 enzymes. Interactions with mannitol may affect its bioavailability in certain formulations.
- Inhibits gastric acid secretion
- Metabolized by cytochrome P450 enzymes
- Interacts with mannitol
- Reversibly inhibits CYP2C19 directly and metabolism-dependently
- For research use only
eMolecules 89352-76-1 | Ambeed | N-Methyl Omeprazole | 100mg | 600851645 | A638530 | MFCD19441777 | 359.44 | C18H21N3O3S
Ambeed | N-Methyl Omeprazole | 100mg | 600851645 | A638530 | 89352-76-1 | MFCD19441777 | 359.440 | C18H21N3O3S